Genmab — December 2012
-
key milestones for 2013
-
positioned for success
-
100 mill usd still to come i ofa
-
i milestones
-
frontline on 6 måneder
-
track record på IND
-
humax næste i 2013
-
firmly slotted
-
De har jo nærmest hele industrien som partnere
-
hexa kan redde alt det der fejler af antistoffer
-
det kan sku godt blive en god forretning
-
det kan blive en patentforlænger?
-
ja det kan det
-
jeg elsker når han siger No risk
-
det var på Daratumumab
-
så er der keymilestones
-
A year of data & deals
-
Yes sir
-
operating loss will være lavere end i 2012
-
reduce cashburn
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind